JPRN-UMIN000019400已完成未知
Prospective study of Sofosbuvir and Ledipasvir for HCV genotype 1 infected Japanese patients - IFN free SL study
Osaka City University and affiliated hospitals0 个研究点目标入组 400 人开始时间: 2015年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnant woman Decompensated cirrhosis Hepatocellular carcinoma Renal impairement (eGFR<30ml/min/1.73m2) Doctors judge as inappropriate
研究者
相似试验
已完成
不适用
Post marketing study of sofosbuvir and ledipasvir for genotype 1 hepatitis C virus infectioHepatitis virus infectionJPRN-UMIN000023271Wakayama Medical University200
尚未招募
不适用
Efficacy and safety of ledipasvir and sofosbuvir in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000018561Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology2,000
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ledipasvir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019468Toranomon Hospital100
已完成
不适用
Effectiveness and safety of ledipasvir and sofosbuvir for patients infected with HCV genotype 1 in clinical practicesChronic hepatitis C genotype 1JPRN-UMIN000024007Kyushu University1,000
已完成
不适用
Efficacy and safety of Ledipasvir/Sofosbuvir in chronic hepatitis C of Genotype1b with chronic kidney disease(eGFR30-60ml/min/1.73m2)Chronic hepatitis CJPRN-UMIN000027851ippon Medical School Chiba Hokusoh Hospital700